Gwyneth Davies
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Davies, Gwyneth; Rowbotham, Nicola J; Smith, Sherie; Elliot, Zoe C; Gathercole, Katie; Rayner, Oli; Leighton, Paul A; Herbert, Sophie; Duff, Alistair Ja; Chandran, Suja; Daniels, Tracey; Nash, Edward F; Smyth, Alan R
Authors
Nicola J Rowbotham
Mrs SHERIE SMITH sherie.smith@nottingham.ac.uk
COCHRANE SYSTEMATIC REVIEWER
Zoe C Elliot
Katie Gathercole
Oli Rayner
Dr PAUL LEIGHTON PAUL.LEIGHTON@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR OF APPLIED HEALTH SERVICES RESEARCH
Sophie Herbert
Alistair Ja Duff
Suja Chandran
Tracey Daniels
Edward F Nash
Alan R Smyth
Abstract
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: “What are effective ways of simplifying the treatment burden of people with CF?” We aimed to summarise the lived experience of treatment burden and suggest research themes aimed at reducing it. An online questionnaire was co-produced and responses subjected to quantitative and thematic analysis. 941 survey responses were received (641 from lay community). People with CF reported a median of 10 (interquartile range: 6–15) current treatments. Seven main themes relating to simplifying treatment burden were identified. Treatment burden is high, extending beyond time taken to perform routine daily treatments, with impact varying according to person-specific factors. Approaches to communication, support, evaluation of current treatments, service set-up, and treatment logistics (obtaining/administration) contribute to burden, offering scope for evaluation in clinical trials or service improvement.
Citation
Davies, G., Rowbotham, N. J., Smith, S., Elliot, Z. C., Gathercole, K., Rayner, O., Leighton, P. A., Herbert, S., Duff, A. J., Chandran, S., Daniels, T., Nash, E. F., & Smyth, A. R. (2020). Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials. Journal of Cystic Fibrosis, 19(3), 499-502. https://doi.org/10.1016/j.jcf.2019.10.025
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 29, 2019 |
Online Publication Date | Nov 14, 2019 |
Publication Date | 2020-05 |
Deposit Date | Nov 5, 2019 |
Publicly Available Date | Nov 15, 2020 |
Journal | Journal of Cystic Fibrosis |
Print ISSN | 1569-1993 |
Electronic ISSN | 1873-5010 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 19 |
Issue | 3 |
Pages | 499-502 |
DOI | https://doi.org/10.1016/j.jcf.2019.10.025 |
Keywords | Treatment burden; cystic fibrosis; clinical trial; co-production; priority setting |
Public URL | https://nottingham-repository.worktribe.com/output/3058224 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1569199319309610 |
Contract Date | Nov 5, 2019 |
Files
Davies_TreatmentBurden_OLS_Supplementaryfile2
(102 Kb)
PDF
Davies_TreatmentBurden_OLS_Supplementaryfile1_Fullsurvey_withLog
(485 Kb)
PDF
BoTmanuscriptbriefcomm Revisedsubmission JCF-D-19-00299R1clean
(182 Kb)
PDF
You might also like
Exploring the challenges of accessing medication for patients with cystic fibrosis
(2021)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search